Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Fredrickson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Laboratory Animal Science|February 1, 1992
Use of ameroid constrictors in the development of renin-dependent hypertension in dogsD P Brooks, T A Fredrickson
Peptides|March 4, 2000
Epithelin mRNA expression in polycystic kidney diseaseS M Ali, P Nambi, T A Fredrickson, et al.
Pharmacology|January 11, 1991
Effect of the dopamine beta-hydroxylase inhibitor, SK&F 102698, on blood pressure in the 1-kidney, 1-clip hypertensive dogD P Brooks, T A Fredrickson, P F Koster, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitorsD P Brooks, P D DePalma, T A Fredrickson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 1992
Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogsD P Brooks, T A Fredrickson, J Weinstock, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependentD P Brooks, R M Edwards, P D Depalma, et al.
British Journal of Pharmacology|April 11, 1992
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogsJ P Hieble, A J Nichols, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Phosphate excretion and phosphate transporter messenger RNA in uremic rats treated with phosphonoformic acidD P Brooks, S M Ali, L C Contino, et al.
Pharmacology|July 22, 1998
Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal diseaseS M Ali, N J Laping, T A Fredrickson, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 11, 2000
Apoptosis in polycystic kidney disease: involvement of caspasesS M Ali, V Y Wong, K Kikly, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Laboratory Animal Science|February 1, 1992
Use of ameroid constrictors in the development of renin-dependent hypertension in dogsD P Brooks, T A Fredrickson
Peptides|March 4, 2000
Epithelin mRNA expression in polycystic kidney diseaseS M Ali, P Nambi, T A Fredrickson, et al.
Pharmacology|January 11, 1991
Effect of the dopamine beta-hydroxylase inhibitor, SK&F 102698, on blood pressure in the 1-kidney, 1-clip hypertensive dogD P Brooks, T A Fredrickson, P F Koster, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitorsD P Brooks, P D DePalma, T A Fredrickson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 1992
Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogsD P Brooks, T A Fredrickson, J Weinstock, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependentD P Brooks, R M Edwards, P D Depalma, et al.
British Journal of Pharmacology|April 11, 1992
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogsJ P Hieble, A J Nichols, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Phosphate excretion and phosphate transporter messenger RNA in uremic rats treated with phosphonoformic acidD P Brooks, S M Ali, L C Contino, et al.
Pharmacology|July 22, 1998
Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal diseaseS M Ali, N J Laping, T A Fredrickson, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 11, 2000
Apoptosis in polycystic kidney disease: involvement of caspasesS M Ali, V Y Wong, K Kikly, et al.
Pageof 2